tiprankstipranks
Advertisement
Advertisement

CTKB Stock Latest News

Cytek Biosciences Faces Rising Risk From U.S.–China Trade Tensions and Tariff Pressures
Company AnnouncementsCytek Biosciences Faces Rising Risk From U.S.–China Trade Tensions and Tariff Pressures
2d ago
CTKB
Cytek Biosciences Balances Growth Momentum With Cost Pressures
PremiumCompany Announcements
Cytek Biosciences Balances Growth Momentum With Cost Pressures
2d ago
CTKB
Cytek Maintained at Hold as Risk‑Reward Stays Balanced; $5 Price Target Reaffirmed
PremiumRatings
Cytek Maintained at Hold as Risk‑Reward Stays Balanced; $5 Price Target Reaffirmed
3d ago
CTKB
Cytek Biosciences Balances Growth With Margin Strain
PremiumCompany Announcements
Cytek Biosciences Balances Growth With Margin Strain
2M ago
CTKB
Cytek Biosciences reports preliminary Q4 revenue $62M, consensus $56.99M
PremiumThe Fly
Cytek Biosciences reports preliminary Q4 revenue $62M, consensus $56.99M
4M ago
CTKB
Cytek Biosciences price target raised to $5 from $4 at TD Cowen
PremiumThe FlyCytek Biosciences price target raised to $5 from $4 at TD Cowen
4M ago
CTKB
Cytek Biosciences assumed with an Equal Weight at Morgan Stanley
Premium
The Fly
Cytek Biosciences assumed with an Equal Weight at Morgan Stanley
5M ago
CTKB
Cytek Biosciences price target lowered to $7.50 from $8 at Piper Sandler
Premium
The Fly
Cytek Biosciences price target lowered to $7.50 from $8 at Piper Sandler
6M ago
CTKB
Cytek Biosciences Earnings Call: Mixed Sentiment and Growth
PremiumCompany Announcements
Cytek Biosciences Earnings Call: Mixed Sentiment and Growth
6M ago
CTKB
Cytek Biosciences Reports Modest Revenue Growth in Q3 2025
PremiumCompany Announcements
Cytek Biosciences Reports Modest Revenue Growth in Q3 2025
6M ago
CTKB
Cautious Hold on Cytek Biosciences Amid Market Stagnation and Growth Uncertainty
PremiumRatings
Cautious Hold on Cytek Biosciences Amid Market Stagnation and Growth Uncertainty
6M ago
CTKB
Cytek Biosciences backs FY25 revenue view $196M-$205M, consensus $195.95M
PremiumThe Fly
Cytek Biosciences backs FY25 revenue view $196M-$205M, consensus $195.95M
6M ago
CTKB
Cytek Biosciences reports Q3 EPS (4c), consensus 1c
PremiumThe FlyCytek Biosciences reports Q3 EPS (4c), consensus 1c
6M ago
CTKB
Cytek Biosciences management to meet virtually with Piper Sandler
Premium
The Fly
Cytek Biosciences management to meet virtually with Piper Sandler
9M ago
CTKB
Cytek Biosciences price target lowered to $4 from $7 at Morgan Stanley
Premium
The Fly
Cytek Biosciences price target lowered to $4 from $7 at Morgan Stanley
9M ago
CTKB
Cytek Biosciences Earnings Call Reveals Mixed Outlook
PremiumCompany Announcements
Cytek Biosciences Earnings Call Reveals Mixed Outlook
9M ago
CTKB
Cytek Biosciences: Q2 2025 Financial Performance Overview
PremiumCompany Announcements
Cytek Biosciences: Q2 2025 Financial Performance Overview
9M ago
CTKB
Cytek Biosciences Faces Market Challenges and Uncertain Growth Prospects Leading to Hold Rating
PremiumRatings
Cytek Biosciences Faces Market Challenges and Uncertain Growth Prospects Leading to Hold Rating
9M ago
CTKB
Cytek Biosciences reports Q2 EPS (4c), consensus (1c)
PremiumThe Fly
Cytek Biosciences reports Q2 EPS (4c), consensus (1c)
9M ago
CTKB
Cytek Biosciences narrows FY25 revenue view to $196M-$200M from $196M-$210M
PremiumThe FlyCytek Biosciences narrows FY25 revenue view to $196M-$200M from $196M-$210M
9M ago
CTKB
Cytek Biosciences Elects New Directors at Annual Meeting
Premium
Company Announcements
Cytek Biosciences Elects New Directors at Annual Meeting
11M ago
8K
CTKB
Cytek Biosciences price target lowered to $7 from $9 at Morgan Stanley
Premium
The Fly
Cytek Biosciences price target lowered to $7 from $9 at Morgan Stanley
12M ago
CTKB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >